On January 2, the U.S. Food and Drug Administration approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human…
The latest research published in the Journal of Acquired Immune Deficiency Syndrome in March revealed that most women living with HIV that were surveyed preferred…
Principally, it was birth-control tablets, then smoking-cessation medicines. Presently, Colorado is on its way to converting into one of the first states in the US…
While new data from the CDC suggests choosing for people between the ages of 13 and 64 years of age, only 40% have ever been…
In a retrospective series on sufferers with HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) who were handled with immune checkpoint inhibitors (ICI),…
Current research gives insight into how HIV may raise the risk of cardiac death in infected people.The decisions, which were written in Circulation and performed…